Andrew Saik - Insider Trading & Ownership

Location
640 Lee Road, Chesterbrook, PA
Summary
The estimated net worth of Andrew Saik is at least $2.72M dollars as of June 24, 2025. Andrew Saik is the Chief Financial Officer of ARVINAS, INC. and owns shares of ARVINAS, INC. (ARVN) stock worth about $2.45M. Andrew Saik is the Chief Financial Officer of VYNE Therapeutics Inc. and owns shares of VYNE Therapeutics Inc. (VYNE) stock worth about $266K.
Signature
/s/ Jared Freedberg, as attorney-in-fact for Andrew Saik
All Insider Reports
All Insider Reports

Ownership of Andrew Saik

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARVN ARVINAS, INC. Chief Financial Officer $2.45M -$43.4K -1.74% Jun 24, 2025
VYNE VYNE Therapeutics Inc. Chief Financial Officer $266K May 28, 2021
ICPT INTERCEPT PHARMACEUTICALS, INC. EVP & Chief Financial Officer Nov 8, 2023
MIST Milestone Pharmaceuticals Inc. Director Jun 10, 2025

Insider Transactions Reported by Andrew Saik:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.